Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients

NCT01652664 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT01652664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01652664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2012
Completion date
March 31, 2014
Enrollment
184 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

elevated iop in pediatric patients, ocular hypertension in pediatric patients, pediatric glaucoma